Gene · 432
Papers2,727
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,727
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| ACE2-independent entry factors for SARS-CoV-2 infection and immune activation. | mBio | 2026 | 41427721 | PubTator, text mining | PubMed |
| Development of Cathepsin B-Responsive GalNAc-PROTACs for Hepatocyte-Targeting Protein Degradation. | J Med Chem | 2026 | 41403144 | PubTator, text mining | PubMed |
| Tumor-specific glyco-detonators: A neuraminidase-3-gated programmable DNA Nanoarchitectonics for liver cancer-exclusive chemotherapy. | J Control Release | 2026 | 41352645 | PubTator, text mining | PubMed |
| Potential of polysaccharides as active targeting agents for nanoparticles toward biological receptors: a review. | Int J Biol Macromol | 2026 | 41344461 | PubTator, text mining | PubMed |
| Proteomic Markers of Dietary Patterns, CKD Progression, and Mortality in the CRIC Study. | Clin J Am Soc Nephrol | 2026 | 41325160 | PubTator, text mining | PubMed |
| CHB-Induced Immune Zonation Chaos Elicited LXRα-mediated Lipid Metabolism Disorders in Kupffer Cells to Induce Cancer Stem Cell Formation. | Adv Sci (Weinh) | 2026 | 41164971 | PubTator, text mining | PubMed |
| TPDdb: the comprehensive database of targeted protein degrader. | Nucleic Acids Res | 2026 | 41091922 | PubTator, text mining | PubMed |
| Causal Relationship Between Serum Zinc Levels and Diabetic Kidney Disease (DKD): A Plasma Proteomics Mediation Study. | Biol Trace Elem Res | 2026 | 40830297 | PubTator, text mining | PubMed |
| Expressive Attribute-Based Proxy Signature Scheme for UAV Networks. | Sensors (Basel) | 2025 | 41516491 | PubTator, text mining | PubMed |
| Special Issue "Targeting of Functional Proteins in Disease Therapeutics: Enzyme Function and Inhibition Studies". | Int J Mol Sci | 2025 | 41515950 | PubTator, text mining | PubMed |
| Mendelian randomization analysis of lipid-lowering drug targets and neuropsychiatric disorders. | Medicine (Baltimore) | 2025 | 41465952 | PubTator, text mining | PubMed |
| Construction and validation of risk models of prognostic genes associated with parthanatos in papillary thyroid carcinoma based on bioinformatics. | Discov Oncol | 2025 | 41331176 | PubTator, text mining | PubMed |
| Prospective association of the triglyceride-glucose index and triglyceride to high-density lipoprotein cholesterol ratio with anxiety risk in a community-based cohort: a UK Biobank study. | BMJ Open | 2025 | 41290299 | PubTator, text mining | PubMed |
| Synthesis and biomedical applications of glycopolymers. | Adv Carbohydr Chem Biochem | 2025 | 41266027 | PubTator, text mining | PubMed |
| Development of new glycosyl-chalcones targeting cancer cells through recognition of cellular carbohydrate receptors. | Future Med Chem | 2025 | 41250945 | PubTator, text mining | PubMed |
| Surface-engineering RNA nanoparticles for targeted and efficient hepatocellular carcinoma drug delivery. | Biomed Mater | 2025 | 41192072 | PubTator, text mining | PubMed |
| Bifunctional LYTAC Mediates Hepatocytes-Hepatic Stellate Cells Crosstalk by Regulating 5-HT2A Receptor Degradation and Antagonism to Synergistically Ameliorate Hepatic Fibrosis. | J Am Chem Soc | 2025 | 41128301 | PubTator, text mining | PubMed |
| What we missed then, AI sees now: Revisiting legacy large extracellular vesicle data to reveal synergistic biomarkers for liver cancer screening. | JHEP Rep | 2025 | 41127881 | PubTator, text mining | PubMed |
| Bi-functional integrin degraders cause stronger anti-proliferative effects than a blocking antibody by modulating distinct downstream signaling. | MAbs | 2025 | 41121746 | PubTator, text mining | PubMed |
| Cholesterol metabolism: molecular mechanisms, biological functions, diseases, and therapeutic targets. | Mol Biomed | 2025 | 41062796 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/432/papers?page=6